Dr. Siegel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
120 Spalding Dr
Ste 111
Naperville, IL 60540Phone+1 630-527-3788Fax+1 630-527-3505
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2012 - 2015
- Loyola University Medical CenterResidency, Internal Medicine, 2008 - 2012
- Loyola University Chicago Stritch School of MedicineClass of 2008
Certifications & Licensure
- OR State Medical License 2013 - Present
- IL State Medical License 2011 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsIgG 4 Autoimmune hepatitis presenting as idiopathic hypereosinophilia syndrome.Darren Kastin, Matthew Siegel, Richard Anderson, Andrew Aronsohn
Hepatology. 2021-04-01 - 9 citationsModified HyperCVAD Versus Bortezomib-HyperCAD in Patients With Relapsed/Refractory Multiple MyelomaMegan M. Saraceni, Emma C. Scott, Richard T. Maziarz, Matthew B. Siegel, Solange Bassale
Clinical Lymphoma, Myeloma & Leukemia. 2018-01-01 - 41 citationsSmall molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma.Matthew B. Siegel, Selina Qiuying Liu, Monika A. Davare, Stephen E. Spurgeon, Marc M. Loriaux
Oncotarget. 2015-05-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: